T. Mackenzie

Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non‐biologic systemic therapies

H. Ali, A. Burden, C. Griffiths, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis

G. Ogg, M. Londei, Yi-Ling Chen, 2019, Science Translational Medicine.

Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study

S. Feldman, L. Naldi, E. Freeman, 2020, Journal of Allergy and Clinical Immunology.